Poly(amido amine) dendrimers as absorption enhancers for oral delivery of camptothecin.

International journal of pharmaceutics

Volumn 456, Issue 1, 2013, Pages 175-185

  Sadekar, S ^a   Thiagarajan, G ^b   Bartlett, K ^b   Hubbard, D ^b   Ray, A ^b   McGill, L D ^b   Ghandehari, H ^b  

^a UNIVERSITY OF UTAH   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CAMPTOTHECIN; DENDRIMER; DRUG CARRIER; PAMAM STARBURST;

ANIMAL; BIOAVAILABILITY; CHEMISTRY; DRUG EFFECTS; FEMALE; INTESTINE ABSORPTION; MOUSE; ORAL DRUG ADMINISTRATION; SMALL INTESTINE; TRANSMISSION ELECTRON MICROSCOPY; ULTRASTRUCTURE;

ADMINISTRATION, ORAL; ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BIOLOGICAL AVAILABILITY; CAMPTOTHECIN; DENDRIMERS; DRUG CARRIERS; FEMALE; INTESTINAL ABSORPTION; INTESTINE, SMALL; MICE; MICROSCOPY, ELECTRON, TRANSMISSION;

EID: 84899038601     PISSN: None     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2013.07.071     Document Type: Article

References (54)

1. J. Aisner Overview of the changing paradigm in cancer treatment: oral chemotherapy Am. J. Health Syst. Pharm. 64 2007 S4 S7
2. A. Beezer A. King I. Martin J. Mitchel L. Twyman C. Wain Dendrimers as potential drug carriers; encapsulation of acidic hydrophobes within water soluble PAMAM derivatives Tetrahedron 59 2003 3873 3880
3. T. Bredholt E.A.O. Dimba H.R. Hagland L. Wergeland J. Skavland K.O. Fossan K.J. Tronstad A.C. Johannessen O.K. Vintermyr B.T. Gjertsen Camptothecin and khat ( Catha edulis Forsk.) induced distinct cell death phenotypes involving modulation of c-FLIP Mol. Cancer 8 2009 101
4. A.S. Chauhan S. Sridevi K.B. Chalasani A.K. Jain S.K. Jain N. Jain P.V. Diwan Dendrimer-mediated transdermal delivery: enhanced bioavailability of indomethacin J. Control. Release 90 2003 335 343
5. A.S. Chauhan N.K. Jain P.V. Diwan A.J. Khopade Solubility enhancement of indomethacin with poly (amidoamine) dendrimers and targeting to inflammatory regions of arthritic rats J. Drug Target. 12 2004 575 583
6. Y. Cheng H. Qu M. Ma Z. Xu P. Xu Y. Fang T. Xu Polyamidoamine (PAMAM) dendrimers as biocompatible carriers of quinolone antimicrobials: an in vitro study Eur. J. Med. Chem. 42 2007 1032 1038
7. Y. Cheng M. Li T. Xu Potential of poly (amidoamine) dendrimers as drug carriers of camptothecin based on encapsulation studies Eur. J. Med. Chem. 43 2008 1791 1795
8. Y. Cheng Q. Wu Y. Li T. Xu External electrostatic interaction versus internal encapsulation between cationic dendrimers and negatively charged drugs: which contributes more to solubility enhancement of the drugs? J. Phys. Chem. B 112 2008 8884 8890
9. C.D. Conover R.B. Greenwald A. Pendri C.W. Gilbert K.L. Shum Camptothecin delivery systems: enhanced efficacy and tumor accumulation of camptothecin following its conjugation to polyethylene glycol via a glycine linker Cancer Chemother. Pharmacol. 42 1998 407 414
10. R. Cortesi E. Esposito A. Maietti E. Menegatti C. Nastruzzi Formulation study for the antitumor drug camptothecin: liposomes, micellar solutions and a microemulsion Int. Pharm. J. 159 1997 95 103
11. A. D’Emanuele D. Attwood Dendrimer–drug interactions Adv. Drug Deliv. Rev. 57 2005 2147 2162
12. M.D. DeMario M.J. Ratain Oral chemotherapy: rationale and future directions J. Clin. Oncol. 16 1998 2557 2567
13. B. Devarakonda R.A. Hill M.M. de Villiers The effect of PAMAM dendrimer generation size and surface functional group on the aqueous solubility of nifedipine Int. J. Pharm. 284 2004 133 140
14. M. El-Sayed M. Ginski C. Rhodes H. Ghandehari Transepithelial transport of poly (amidoamine) dendrimers across Caco-2 cell monolayers J. Control. Release 81 2002 355 365
15. M. El-Sayed M. Ginski C.A. Rhodes H. Ghandehari Influence of surface chemistry of poly (amidoamine) dendrimers on Caco-2 cell monolayers J. Bioact. Compatible Polym. 18 2003 7 22
16. M. El-Sayed C.A. Rhodes M. Ginski H. Ghandehari Transport mechanism(s) of poly (amidoamine) dendrimers across Caco-2 cell monolayers Int. J. Pharm. 265 2003 151 157
17. D.L. Emerson Liposomal delivery of camptothecins Pharm. Sci. Technol. 3 2000 205 209
18. J. Fassberg V.J. Stella A kinetic and mechanistic study of the hydrolysis of camptothecin and some analogues J. Pharm. Sci. 81 1992 676 684
19. D. Goldberg H. Ghandehari P. Swaan Cellular entry of G3.5 poly (amido amine) dendrimers by clathrin-and dynamin-dependent endocytosis promotes tight junctional opening in intestinal epithelia Pharm. Res. 27 2010 1547 1557
20. D. Goldberg N. Vijayalakshmi P. Swaan H. Ghandehari G3.5 PAMAM dendrimers enhance transepithelial transport of SN38 while minimizing gastrointestinal toxicity J. Control. Release 150 2011 318 325
21. E. Gupta V. Vyas F. Ahmed P. Sinko T. Cook E. Rubin Pharmacokinetics of orally administered camptothecins Ann. N.Y. Acad. Sci. 922 2000 195 204
22. U. Gupta H.B. Agashe A. Asthana N. Jain Dendrimers: novel polymeric nanoarchitectures for solubility enhancement Biomacromolecules 7 2006 649 658
23. M. Harada H. Sakakibara T. Yano T. Suzuki S. Okuno Determinants for the drug release from T-0128, camptothecin analogue-carboxymethyl dextran conjugate J. Control. Release 69 2000 399 412
24. A. Hatefi B. Amsden Camptothecin delivery methods Pharm. Res. 19 2002 1389 1399
25. J. Hu Y. Cheng Y. Ma Q. Wu T. Xu Host–guest chemistry and physicochemical properties of the dendrimer – mycophenolic acid complex J. Phys. Chem. B 113 2008 64 74
26. J. Hu Y. Cheng Q. Wu L. Zhao T. Xu Host–guest chemistry of dendrimer-drug complexes, 2. Effects of molecular properties of guests and surface functionalities of dendrimers J. Phys. Chem. B 113 2009 10650 10659
27. X. Huang Z. Wu W. Gao Q. Chen B. Yu Polyamidoamine dendrimers as potential drug carriers for enhanced aqueous solubility and oral bioavailability of silybin Drug Dev. Ind. Pharm. 37 2011 419 427
28. W. Ke Y. Zhao R. Huang C. Jiang Y. Pei Enhanced oral bioavailability of doxorubicin in a dendrimer drug delivery system J. Pharm. Sci. 97 2008 2208 2216
29. W.D. Kingsbury J.C. Boehm D.R. Jakas K.G. Holden S.M. Hecht G. Gallagher M.J. Caranfa F.L. McCabe L.F. Faucette R.K. Johnson Synthesis of water-soluble (aminoalkyl) camptothecin analogs: inhibition of topoisomerase I and antitumor activity J. Med. Chem. 34 1991 98 107
30. K.M. Kitchens R.B. Kolhatkar P.W. Swaan N.D. Eddington H. Ghandehari Transport of poly (amidoamine) dendrimers across Caco-2 cell monolayers: influence of size, charge and fluorescent labeling Pharm. Res. 23 2006 2818 2826
31. K.M. Kitchens A.B. Foraker R.B. Kolhatkar P.W. Swaan H. Ghandehari Endocytosis and interaction of poly (amidoamine) dendrimers with Caco-2 cells Pharm. Res. 24 2007 2138 2145
32. K.M. Kitchens R.B. Kolhatkar P.W. Swaan H. Ghandehari Endocytosis inhibitors prevent poly (amidoamine) dendrimer internalization and permeability across Caco-2 cells Mol. Pharm. 5 2008 364 369
33. J. Lin X. Liu Y. Bao S. Hou L. An X. Lin Effects of isocamptothecin, a novel camptothecin analogue, on proliferation, apoptosis and telomerase activity in HaCaT cells Exp. Dermatol. 17 2008 530 536
34. Y. Lin K. Khanafer M.E.H. El-Sayed Quantitative evaluation of the effect of poly (amidoamine) dendrimers on the porosity of epithelial monolayers Nanoscale 2 2010 755 762
35. B. Lundberg Biologically active camptothecin derivatives for incorporation into liposome bilayers and lipid emulsions Anticancer Drug Des. 13 1998 453 461
36. M. Markowicz P. Szymański M. Ciszewski A. Kłys E. Mikiciuk-Olasik Evaluation of poly (amidoamine) dendrimers as potential carriers of iminodiacetic derivatives using solubility studies and 2D-NOESY NMR spectroscopy J. Biol. Phys. 2012 1 20
37. J. O’Leary F. Muggia Camptothecins: a review of their development and schedules of administration Eur. J. Cancer 34 1998 1500 1508
38. T. Ooya J. Lee K. Park Hydrotropic dendrimers of generations 4 and 5: synthesis, characterization, and hydrotropic solubilization of paclitaxel Bioconjug. Chem. 15 2004 1221 1229
39. G. Pistolis A. Malliaris Study of poly (propylene imine) dendrimers in water, by exciplex formation Langmuir 18 2002 246 251
40. G. Pistolis A. Malliaris C. Paleos D. Tsiourvas Study of poly (amidoamine) starburst dendrimers by fluorescence probing Langmuir 13 1997 5870 5875
41. M.L. Rothenberg Irinotecan (CPT-11): recent developments and future directions-colorectal cancer and beyond Oncologist 6 2001 66
42. S. Sadekar H. Ghandehari Transepithelial transport and toxicity of PAMAM dendrimers: implications for oral drug delivery Adv. Drug Deliv. Rev. 64 2012 571 588
43. S. Sakuma Z.R. Lu P. Kopečková J. Kopeček Biorecognizable HPMA copolymer–drug conjugates for colon-specific delivery of 9-aminocamptothecin J. Control. Release 75 2001 365 379
44. D.O. Scott D.S. Bindra V.J. Stella Plasma pharmacokinetics of the lactone and carboxylate forms of 20 (S)-camptothecin in anesthetized rats Pharm. Res. 10 1993 1451 1457
45. J.W. Singer P. Vries R. Bhatt J. Tulinsky P. Klein C. Li L. Milas R.A. Lewis S. Wallace Conjugation of camptothecins to poly(l-glutamic acid) Ann. N.Y. Acad. Sci. 922 2000 136 150
46. J.S. Stehlin E.A. Natelson H.R. Hinz B.C. Giovanella P. Ipolyi K. Fehin T.P. Trezona D.M. Vardeman N.J. Harris A.K. Marcee M. Potmesil H. Pinedo Camptothecins: New Anticancer Agents 1995 CRC Press, Inc Florida 59 65
47. S.M. Sugarman Y.Y. Zou K. Wasan K. Poirot R. Kumi S. Reddy R. Perez-Soler Lipid-complexed camptothecin: formulation and initial biodistribution and antitumor activity studies Cancer Chemother. Pharmacol. 37 1996 531 538
48. J.M.M. Terwogt J.H.M. Schellens W.W. Huinink J.H. Beijnen Clinical pharmacology of anticancer agents in relation to formulations and administration routes Cancer Treat. Rev. 25 1999 83 101
49. G. Thiagarajan A. Ray A. Malugin H. Ghandehari PAMAM-camptothecin conjugate inhibits proliferation and induces nuclear fragmentation in colorectal carcinoma cells Pharm. Res. 27 2010 2307 2316
50. G. Thiagarajan K. Gresih H. Ghandehari Charge affects the oral toxicity of poly(amido amine) dendrimers Eur. J. Pharm. Biopharm 84 2013 330 334
51. D.A. Tomalia H. Baker J. Dewald M. Hall G. Kallos S. Martin J. Roeck J. Ryder P. Smith A new class of polymers: starburst-dendritic macromolecules Polym. J. 17 1985 117 132
52. D.A. Tomalia A.M. Naylor W.A. Goddard III Starburst dendrimers: molecular-level control of size, shape, surface chemistry, topology, and flexibility from atoms to macroscopic matter Angew. Chem. Int. Ed. 29 1990 138 175
53. N. Vijayalakshmi A. Ray A. Malugin H. Ghandehari Carboxyl-terminated PAMAM-SN38 conjugates: synthesis, characterization, and in vitro evaluation Bioconjug. Chem. 21 2010 1804 1810
54. C. Yiyun X. Tongwen Dendrimers as potential drug carriers. Part I. Solubilization of non-steroidal anti-inflammatory drugs in the presence of polyamidoamine dendrimers Eur. J. Med. Chem. 40 2005 1188 1192